ClinicalTrials.gov
public full text
Public Domain
FAAH Availability in Psychiatric Disorders: A PET Study
The aim of the present study is to examine Fatty Acid Amide Hydrolase (FAAH) availability in humans, including healthy individuals and across a spectrum of psychiatric disorders in which alterations in the endocannabinoid system are observed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment#896061
- Adapting a Regulation of Craving Magnetic Resonance Imaging Task to Generate Functional Repetitive Transcranial Magnetic Stimulation Targets for the Ventromedial and Dorsolateral Prefrontal Cortex in Treatment-Seeking Participants with Cannabis Use Disorder#341964
- Study of Dronabinol Treatment for Depression and/or Anxiety in Older Patients#1030720
- The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.#380949
- Psychiatric disorders at the crossroads of neurovascular, immune, and metabolic dysregulation: Examining comorbidities from a biopsychosocial and dimensional perspective across the lifespan.#375595
Record · ID 907538
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive